A open label, randomized, comparative study on efficacy, safety and reduction of diabetic complications, with regimens of metformin, glimeperide, & vildagliptin vs metformin, Glimeperide, & dapagliflozin in type – 2 diabetic patients.

Trial Profile

A open label, randomized, comparative study on efficacy, safety and reduction of diabetic complications, with regimens of metformin, glimeperide, & vildagliptin vs metformin, Glimeperide, & dapagliflozin in type – 2 diabetic patients.

Not yet recruiting
Phase of Trial: Phase III/IV

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Dapagliflozin (Primary) ; Glimepiride; Metformin; Vildagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top